当前位置: X-MOL 学术Antimicrob. Agents Chemother. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-09-13 , DOI: 10.1128/aac.01121-21
Mallika Imwong 1, 2 , Kanokon Suwannasin 2 , Suttipat Srisutham 3 , Ranitha Vongpromek 4 , Cholrawee Promnarate 4 , Aungkana Saejeng 5 , Aung Pyae Phyo 6 , Stephane Proux 7 , Tiengkham Pongvongsa 8 , Nguon Chea 9 , Olivo Miotto 2, 10, 11 , Rupam Tripura 2, 11 , Chau Nguyen Hoang 12 , Lek Dysoley 9 , Nghia Ho Dang Trung 12 , Thomas J Peto 2, 11 , James J Callery 2 , Rob W van der Pluijm 2 , Chanaki Amaratunga 2, 11 , Mavuto Mukaka 2, 11 , Lorenz von Seidlein 2, 11 , Mayfong Mayxay 11, 13, 14 , Nguyen Thanh Thuy-Nhien 12 , Paul N Newton 11 , Nicholas P J Day 2, 11 , Elizabeth A Ashley 11, 14 , Francois H Nosten 7, 11 , Frank M Smithuis 6, 11 , Mehul Dhorda 2, 3, 11 , Nicholas J White 2, 11 , Arjen M Dondorp 2, 11
Affiliation  

Increasing drug resistance in Plasmodium falciparum to artemisinins and their ACT partner drugs jeopardises effective antimalarial treatment. Resistance is worst in the Greater Mekong Subregion. Monitoring genetic markers of resistance can help to guide ...

中文翻译:

恶性疟原虫多药耐药的演变:大湄公河次区域遗传耐药标记的纵向研究

恶性疟原虫对青蒿素及其 ACT 伙伴药物的耐药性增加,危及有效的抗疟治疗。大湄公河次区域的阻力最严重。监测耐药性遗传标记有助于指导...
更新日期:2021-09-14
down
wechat
bug